|LAST TRADE||CHANGE (%)||VOLUME|
|BID SIZE||BID ($)||ASK ($)||ASK SIZE|
XPH Fund Description
The SPDR S&P Pharmaceuticals ETF tracks an equal-weighted index of US pharmaceutical companies.
XPH FactSet Analytics Insight
XPH offers equal-weighted exposure to roughly
“a rather volatile fund relative to the industry” 30 US pharmaceutical companies, stretching across all market-cap sizes. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. It also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. XPH sees significant daily trading volume with small spreads, and underlying liquidity is excellent for block trades. It's also a very Efficient fund, with a low fee and tight tracking that lags by less than XPH's expense ratio. Overall, XPH is a solid way to capture a less concentrated version of the pharma market.
XPH Top 10 Countries
XPH Top 10 Sectors
XPH Top 10 Holdings View All
XPH Summary Data
XPH Portfolio Data
XPH Index Data
Related ETFs to XPH
XPH Portfolio Management
XPH Tax Exposures
XPH Fund Structure
XPH FactSet Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of XPH. XPH is rated a 5 out of 5.